rs146269871
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 4P and 4B. PM1PM2BP4_Strong
The NM_000441.2(SLC26A4):āc.1616T>Cā(p.Ile539Thr) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000148 in 1,510,204 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/23 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000441.2 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC26A4 | NM_000441.2 | c.1616T>C | p.Ile539Thr | missense_variant, splice_region_variant | 15/21 | ENST00000644269.2 | NP_000432.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC26A4 | ENST00000644269.2 | c.1616T>C | p.Ile539Thr | missense_variant, splice_region_variant | 15/21 | NM_000441.2 | ENSP00000494017.1 |
Frequencies
GnomAD3 genomes AF: 0.000690 AC: 105AN: 152206Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000203 AC: 51AN: 250870Hom.: 0 AF XY: 0.000111 AC XY: 15AN XY: 135604
GnomAD4 exome AF: 0.0000869 AC: 118AN: 1357880Hom.: 0 Cov.: 23 AF XY: 0.0000748 AC XY: 51AN XY: 682078
GnomAD4 genome AF: 0.000689 AC: 105AN: 152324Hom.: 0 Cov.: 32 AF XY: 0.000658 AC XY: 49AN XY: 74494
ClinVar
Submissions by phenotype
not provided Uncertain:2Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Jan 08, 2025 | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 26934580) - |
Uncertain significance, criteria provided, single submitter | clinical testing | Athena Diagnostics | Sep 17, 2018 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 18, 2024 | - - |
Pendred syndrome Uncertain:2
Uncertain significance, no assertion criteria provided | clinical testing | Natera, Inc. | Nov 11, 2019 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Sep 05, 2021 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Aug 04, 2016 | The p.Ile539Thr variant in SLC26A4 has not been previously reported in individua ls with hearing loss, hearing loss with EVA, or Pendred syndrome. However, this variant was identified in 0.3% (27/10310) of African chromosomes by the Exome Ag gregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs146269871). This variant is located in the second base of the exon. The 3' splice site of th is exon resembles the minor class of the splice consensus sequence, of which the second base of the exon is included. Computational prediction tools and conserv ation analyses do not provide strong support for or against an impact to splicin g or to the protein. In summary, the clinical significance of the p.Ile539Thr va riant is uncertain. - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 11, 2022 | The c.1616T>C (p.I539T) alteration is located in exon 15 (coding exon 14) of the SLC26A4 gene. This alteration results from a T to C substitution at nucleotide position 1616, causing the isoleucine (I) at amino acid position 539 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Autosomal recessive nonsyndromic hearing loss 4 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Sep 05, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at